MedPath

AGILE THERAPEUTICS INC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
$10.4M
Website

Clinical Trials

8

Active:0
Completed:8

Trial Phases

3 Phases

Phase 1:4
Phase 2:1
Phase 3:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Phase 1
4 (50.0%)
Phase 3
3 (37.5%)
Phase 2
1 (12.5%)

Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System

Phase 3
Completed
Conditions
Healthy
Interventions
Drug: AG200-15
First Posted Date
2014-06-09
Last Posted Date
2020-05-06
Lead Sponsor
Agile Therapeutics
Target Recruit Count
2032
Registration Number
NCT02158572

Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2012-06-20
Last Posted Date
2018-01-23
Lead Sponsor
Agile Therapeutics
Target Recruit Count
36
Registration Number
NCT01623466

Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: AG200-15
First Posted Date
2011-08-23
Last Posted Date
2018-12-31
Lead Sponsor
Agile Therapeutics
Target Recruit Count
24
Registration Number
NCT01422135

Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: AG200-15
First Posted Date
2011-06-20
Last Posted Date
2018-07-31
Lead Sponsor
Agile Therapeutics
Target Recruit Count
24
Registration Number
NCT01375946
Locations
🇺🇸

Clinical Pharmacology of Miami, Inc., Miami, Florida, United States

Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control

Phase 2
Completed
Conditions
Ovulation Suppression
Interventions
First Posted Date
2010-11-30
Last Posted Date
2018-07-05
Lead Sponsor
Agile Therapeutics
Target Recruit Count
123
Registration Number
NCT01250210
  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath